Background. There is evidence that brain death causes changes in peripheral organs. Marked inflammation is found in organs collected during experimental brain death and clinical studies indicate that, despite genetic mismatch, organs obtained from living donors show improved survival over those from brain-dead donors. The aim of the present clinical research was to explore changes in the transcriptional profile of livers from brain-dead organ donors. Methods. Using the cDNA macroarray technique, we compared gene expression in liver biopsies from 21 brain-dead organ donors and in normal liver tissue obtained during resection of benign focal lesions. Results. Analysis of gene expression showed significant differences in the mRNA levels of 117 genes. There was reduced expression of 93 genes whereas expression of 24 genes was enhanced. Downregulated pathways included transcripts related to morphogenesis, blood coagulation, complement cascade, amine metabolism, lipid metabolism, nucleic acid metabolism, biodegradation of xenobiotics, signal transduction, and transcription. Conversely, there was induction of genes related to acute phase response, damage-related response, electron transport, and energy metabolism. Conclusions. The present research demonstrates major changes in the transcriptional profile of livers from brain-dead organ donors. The presence of both down-and upregulated gene families suggests that the alteration in transcriptional profile is not a consequence of death-associated organ failure, but rather, an active change in regulatory mechanisms.
L
ong-term survival rates of solid organ allografts have improved relatively little despite more effective immunosuppression, better organ preservation techniques, and advances in perioperative management. The use of grafts of diminished quality due to organ shortage has disclosed a variety of donor-associated risk factors that may adversely influence transplantation outcome. In addition to the commonly accepted donor-related factors such as old age or organ pathology, it appears that brain death itself has detrimental effects on graft survival (1) . Experimental and clinical studies determined changes in hemodynamic, metabolic, and neurohormonal host responses following brain death (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) . These studies indicate that brain death causes alterations in peripheral organs which could contribute to the inferior outcome of organs from brain-dead donors relative to living donors.
Information on brain death-associated organ damage comes principally from systematic studies in preclinical models. Lung, heart, kidney, and liver were all found to be altered by brain death (2) (3) (4) (5) (6) . Kidneys and livers transplanted from brain-dead rats suffered from increased rates of primary nonfunction and lower graft survival (12, 13) . Increased white cell infiltration and expression of vascular cell adhesion molecule-1 was observed in lungs of brain-dead rats (2) and lung function after transplantation was significantly worse than in allografts from living donors (2) . Proinflammatory cytokine concentration was increased in bronchoalveolar lavage of lungs from brain dead rats (3) . In hearts from brain-dead rats, there was enhanced expression of mRNAs for intercellular adhesion molecule-1, vascular adhesion molecule-1, interleukin-1␤, and interleukin-6 (4). Donor brain death appeared an important risk factor for chronic kidney rejection and transplantation-associated alterations, including proteinuria (5) . Kidneys from brain-dead animals also showed enhanced transcription of cytokines and progressive deterioration of renal morphology (5) . A study on kidney isografts demonstrated early, nonantigen-related, cellular and molecular changes occurring in organs from brain dead donors relative to those from living controls (14) . Immunohistology showed that isografts from brain-dead donors were highly infiltrated by leukocytes with intense upregulation of their products, whereas kidneys from living donors showed virtually no changes (14) . Hemodynamic instability associated with brain death can contribute to deterioration of peripheral organs (6) . These changes may predispose the graft to additional ischemia/reperfusion injury during the transplant process and accelerate rejection after transplantation (6) . Apoptosis induction and increased expression of apoptosisrelated proteins was observed in hepatocytes from brain dead animals (15) . Recently, a cDNA-microarray study in rats identified a substantial number of differentially expressed genes in brain-dead donor kidneys including signal transduction, inflammation, and coagulation (16) .
The detrimental changes observed during experi-mental brain death were confirmed in the less abundant clinical studies. Inflammatory changes were found in cadaveric donor livers that showed increased proportion of CD3ϩ lymphocytes, CD68ϩ monocytes, and macrophages relative to livers from living donors (11) . Of particular interest with regard to detrimental effects of brain death on peripheral organs, livers obtained from non-heartbeating donors expressed lower levels of ICAM-1 relative to brain-dead donor livers (17) . The presence of interstitial leukocytes and the early adhesion molecule E-selectin in brain-dead donor kidneys indicates the presence of an inflammatory process before organ retrieval (10) . An interesting observation is that transplantation outcome appears to be negatively influenced by upregulation of inflammatory molecules such as intercellular adhesion molecule 1 and vascular cell adhesion molecule in the donor organ (8) . Although the above studies described inflammatory changes and specific functional alterations in organs from brain-dead organ donors, there is no evaluation of collective changes in different cell pathways. Using the technique of cDNA macroarray, we determined changes in the transcriptional profile of livers from brain-dead organ donors relative to normal livers.
Pretreatment of the multiorgan donor could be a novel strategy to improve transplantation outcome and to expand the donor pool (9) . However, this could better be achieved after a precise identification of the altered pathways.
PATIENTS AND METHODS
Liver biopsies were obtained from 21 brain-dead organ donors, 9 females and 12 males, mean age 47.2 years (range 21-74). The causes of death were: 10 traumatic brain injuries (TBI), nine subarachnoid hemorrhages (SAH), and two respiratory arrests. The inclusion criterion was appropriateness for transplantation. Patients with malignancy or hepatic viral infections were excluded. All the livers were transplanted successfully. There was no delayed graft function or primary nonfunction. Control liver samples were obtained from 10 subjects, six females and four males, mean age 45.0 years (range 22-61) during resection of angiomas. Donor relatives and living patients gave their informed consent to the study.
Sample Preparation for cDNA Expression Arrays
Needle biopsy (16-gauge) was performed before cold ischemia and organ harvest. The tissue portion used for molecular biology analysis was a fraction of the sample obtained for histological evaluation. All samples were immediately submerged in RNAlater tissue storage reagent (Ambion, Austin, TX) and transferred to -80°C until processing. Tissue samples were homogenized with an Ultra-Turrax tissue homogenizer (IKA Labortechnik, Staufen, Germany). Total RNA was isolated using the Atlas Pure Total RNA extraction kit (Clontech, Palo Alto, CA) and treated with RNAase-free DNAase I according to the manufacturer's instructions. RNA integrity was evaluated by denaturing formaldehyde/agarose gel electrophoresis for each sample. Equal amounts of total RNA were used to construct three independent pools of brain-dead donors and two pools of living subjects. Braindead donors were randomly assigned to three pools, each of them consisting of seven subjects; control samples were randomly separated into two pools, both composed of five subjects. RNA samples were pooled in an effort to reduce the effects of biological variation (18) , to ensure sufficient RNA for gene array analysis, and allow use of the same filter arrays throughout the experiments.
cDNA Macroarray Hybridization
Gene expression analysis was performed using Atlas Human 3.6 Arrays (Clontech). This set of three nylon macroarrays include more than 3500 spotted cDNA of known and functionally annotated genes. cDNA are 200 to 600 bp long and selected for low homology to other genes. A complete list of all the genes on the arrays, including array coordinates and GenBank accession numbers, is available at Clontech web site (http://orders.clontech.com/clontech/atlas/genelists/).
Radiolabeled complex probes were synthesized by reverse transcription using 5 pg of pooled total RNA, [␣- Array membranes were prehybridized in ExpressHyb buffer (Clontech). The 32 P-labeled probes were denatured, diluted with carrier DNA, and added to each membrane in equal amounts. Hybridization was allowed to proceed for 18 h at 68°C. After three high-stringency washes, membranes were exposed to a storage phosphor screen (Molecular Dynamics) for 48 h. Phosphor screens were scanned at 100 m resolution and images were acquired using a 8600 Typhoon Variable Mode Imager (Amersham Biosciences). cDNA probes were then stripped from the arrays by SDS boiling solution, and filters were re-used for other two hybridization experiments.
Analysis of Macroarray Data

Normalization and Filtering
Phosphorimager scans were analyzed using AtlasImage software (version 2.7, Clontech). A given gene was considered to be detectable when its intensity was at least twice the global external background of the array. The background level was subtracted from the intensity of each spot to generate the raw data for each gene. Raw data were normalized according to the sum of the intensities global normalization method. The normalization coefficient was obtained by dividing the global intensity of each array by the global intensity of a reference array. The reference arrays were obtained by averaging the normalized signal intensities of the two set of arrays hybridized with the pools of control RNAs (living patients). The ratio of the signal intensities between brain-dead and living patients was calculated for each gene, comparing separately the pooled samples in the three hybridization experiments. We set the following arbitrary criterion to determine differential expression induced during brain death: the gene had to be induced or repressed at least twofold over baseline (the expression level in living patients) in all replicate arrays. Fold change is expressed as the average of the three replicates. 
Gene Classification
Annotation of gene functions was performed combining information from several public databases. The selected genes were first analyzed using the web-based, client/server application Database for Annotation, Visualization and Integrated Discovery (DAVID, http://apps1.niaid.nih.gov/david/) (19) . Genes that remained unclassified were assigned manually based on information retrieved from the NCBI Entrez Gene Database (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dbϭgene).
Pattern Identification
Overrepresentation analysis was performed on differentially expressed genes using the Entrez Gene identifiers and the Expression Analysis Systematic Explorer tool (EASE version 2.2, http://apps1.niaid.nih.gov/david/ease1.htm) (20) . EASE is an algorithm that provides statistical methods to discover enriched biological themes. It compares the representation of functional classes and pathways for genes within differentially regulated subset to the entirety represented on the array. EASE performs a conservative adjustment of the Fisher exact test to calculate the probability that the composition of the differentially expressed set occurred by chance. EASE was used to test Gene Ontology terms (http://www. geneontology.org) for "biological process" and to identify significantly over-represented biological pathways based on KEGG database (http://www.genome.ad.jp/kegg).
Real-time Reverse Transcription PCR Analysis
Expression of 10 transcripts was evaluated using realtime RT-PCR based on TaqMan methodology, using individual unpooled RNA specimens. PCR was performed in an ABI PRISM 7000 sequence detection system (Applied Biosystems, Foster City, CA). The assay identification numbers for selected genes were Hs00234140_m1 for chemokine (C-C motif) ligand 2 (CCL2), Hs00609691_m1 for chitinase 3-like 1 (CHI3L1), Hs00156548_m1 for clusterin (CLU), Hs00174575_ m1 for chemokine (C-C motif) ligand 5 (CCL5), Hs00167927_ m1 for cytochrome P450 1A2 (CYP1A2), Hs00152928_m1 for early growth response 1 (EGR1), Hs00230853_m1 for hepatocyte nuclear factor 4 alpha (HNF4A), Hs00188074_m1 for lipopolysaccharide binding protein (LBP), Hs00269660_s1 for ras homolog gene member B (RHOB), Hs00153674_m1 for alpha-1 antitrypsin (SERPINA3). To normalize for differences in the amount of sample RNA added to each reaction mixture, GAPDH was selected as an endogenous control. For every transcript, the sample with the lowest expression level was arbitrarily designated as the calibrator. Relative quantitation of gene expression (fold change) was performed using the comparative C T method (⌬⌬C T ): the amount of target, normalized to the endogenous reference and relative to the calibrator, is given by the formula 2 -(⌬⌬CT)
. The Mann-Whitney U test was used to compare differences in fold changes; a probability value Ͻ0.05 was considered statistically significant.
RESULTS
Transcriptional Profile in Livers from Braindead Donors and Controls
Analysis of the transcriptional profile showed 117 genes with a Ն2.0-fold change in expression level in livers from brain-dead donors relative to controls. Expression of 93 genes was reduced, whereas that of 24 was enhanced. RNAs for extracellular matrix glycoprotein FBLN1, atrophin 1, and the cytochrome P450 CYP1A2 showed the greatest transcriptional repression. Conversely, extracellular matrix structural constituent CHI3L1, damage-associated protein S100A8, and oxidative stress response protein GPX2 were markedly upregulated.
Transcripts altered in brain-dead subjects are listed in Table 1 . Livers from brain dead patients had marked downregulation of several metabolism related transcripts, including amino acid, hyaluronal, alcohol, glycolipid, nitrogen, and nucleic acid metabolism. Expression of genes involved in xenobiotic biodegradation was also reduced. Other downregulated gene families included complement and coagulation cascades (BF, C1S, and C7; F5, F12, LMAN1, PLG, and SERPINC1), immune response (AZGP1, B2M, CLU, HLA-DPA1, CCL5, and CCL21), morphogenesis (AHSG, ATN1, MYL9, insulin-like growth factor binding proteins), signal transduction (AGTRL1, APP, CHP, FGF4, PRKAR1B, and RHOB), transcription (EGR1, HNF4A, ID2, MLLT2, NME2, SREBF1, and ZFP36L1), and solute transport (GC, SLC16A1, TF, and TTR). The mean fold-change for these genes ranged from Ϫ2.0 to Ϫ19.3. Donor livers showed increased expression of genes related to acute-phase response (LBP, ORM1, and SERPINA3), inflammation (CCL2, S100A8), and mitochondrial respiratory chain (cytochrome C oxidase subunits, NDUFA4). The mean fold change for these genes ranged from ϩ2.1 to ϩ13.0.
Validation of the Macroarray Data Using Realtime RT-PCR
An independent evaluation of 10 array-identified genes was performed using real time RT-PCR on individual RNA samples. Six genes (CCL5, CLU, CYP1A2, EGR1, HNF4A, and RHOB) were downregulated in liver donors, whereas four were upregulated (CCL2, CHI3L1, LBP, and SERPINA3). All the modifications in gene expression detected by macroarray analysis were confirmed by the RT-PCR, although there were small differences in the change size (Fig. 1) . As PCR and macroarray tests were performed on individual and pooled RNAs respectively, consistency of results between the two techniques is of particular value. This observation reinforces the idea that pooling of samples does not detract from accuracy of gene expression estimation.
Functional Classification
Classification of main gene function (Table 1) was performed using DAVID and public databases. To identify functionally related gene sets that are differentially perturbed in livers from brain-dead organ donors, we used EASE overrepresentation analysis (Fig. 2) . The main Gene Ontology categories associated with brain death were ( Fig. 2A) : wounding and/or stress responses (PϽ0.00001), including immune and inflammatory responses, oxidative stress response, blood coagulation and complement activation; amine (PϽ0.0001) and lipid (PϽ0.001) metabolism, including ethanol, amino acid, energy and steroid metabolism and biosynthesis, and regulation of translation (PϽ0.01). KEGG cellular and metabolic pathways altered in brain-dead donors (Fig. 2B) included fatty acid, bile acid and amino acid metabolism and/or 
DISCUSSION
The novelty of the present results consists primarily in the identification of previously unknown changes in the expression level of a large number of genes in livers of braindead organ donors. As shown in Figure 2 , critical gene families are altered in livers from brain-dead organ donors including downregulation of pathways of paramount importance for liver control of metabolism, morphogenesis, blood coagulation, and complement cascade. The concomitant upregulation of acute phase and inflammatory response genes confirms and expands previous observations in clinical and experimental brain death (4, 8, 16) . The data indicate existence of an intense host response reaction in brain-dead subjects. Because the central nervous system and peripheral organs communicate via neuronal pathways and soluble mediators (21, 22) , it is possible that alteration in peripheral organs is related to the severe brain disorder that occurs before brain death.
Crucial transcripts related to metabolism control and transport system, two key liver functions, were downregulated in brain-dead subjects. In particular, expression of enzymes essential for amino acid metabolism (i.e., argininosuccinate synthetase, carbamoyl-phosphate synthetase 1, and glycine amidinotransferase), glycolipid metabolism (i.e., alcohol dehydrogenases, acetyl-Coenzyme A acyltransferase 1, acyl-CoA synthetase long-chain family member 1), and bile acid biosynthesis (including CYP27A1) was significantly reduced.
Other prominent biosynthetic liver pathways were impaired, including complement and coagulation cascade components. Regulatory molecules in both the classical and the alternative pathway of complement activation, such as BF, C1S, and C7 (23), were reduced. Other downregulated molecules were CLU, which inhibits complement-mediated cytolysis (24) , and the coagulation factor V, an essential factor in the blood coagulation cascade that contributes to activate prothrombin to thrombin (25) .
Several members of the cytochrome P450 family, such as CYP1A2 and CY3A4, were downregulated in donor livers. These proteins are involved in lipid and cholesterol synthesis and catalyze drug metabolism reactions (26) . CY3A4-encoded protein is induced by glucocorticoids and certain pharmacological agents. The enzyme is necessary to metabolism of a substantial proportion of the drugs currently used (27) , including acetaminophen, codeine, cyclosporin A, diazepam, and erythromycin. Its reduction may have, therefore, dire consequences in drug clearance.
In brain-dead donor livers, there was reduced expression of molecules involved in defense and repair mechanisms including transcription factors, signal transduction molecules, and molecules related to morphogenesis and development (i.e., atrophin-1, insulin-like growth factor binding proteins). This may reflect a dysfunction of liver regenerative capability. Insulin-like growth factors, their receptors, and their binding proteins modulate cell proliferation and apoptosis. IGFBP-1 plays an important role in cell growth and defense, including regulation of metabolic and vascular homeostasis (28) . IGFBP3 functions include transport of IGF1 and IGF2 in the circulation and modulation of IGF bioactivity (29) . As the liver is the main source of serum IGFBPs, the concentration of these proteins is considered an index of liver function (30). Brain death was associated with marked repression of IGFBPs transcription. Moreover, there was reduction of ras homolog gene member B (RHOB), a small GTP binding protein induced by genotoxic stress that regulates DNA synthesis, cell growth and maintenance, and cytoskeleton remodeling (31) . Certain transcription factors (EGR1, ZFP36L1), belonging to the group of immediate early response genes, were also significantly downregulated. These genes respond to extracellular stimuli such as growth factors and hormones that rapidly induce their expression (32) . In particular, EGR1 is associated with liver regeneration (33) . This transcription factor contains three zinc fingers that recognize a GC-rich sequence in the promoter regions of genes associated with cell proliferation and differentiation (34) .
The marked downregulation of hepatocyte nuclear factor 4 ␣ (HNF4A), a prominent hepatic transcription factor that activates crucial liver-specific genes, can profoundly affect liver function. Indeed, the genes controlled by HNF4A include albumin, CYP3A4, and hepatocyte nuclear factor 1 ␣ (35). HNF4A is essential for morphologic and functional differentiation of hepatocytes, accumulation of hepatic glycogen stores, lipid metabolism, and generation of a hepatic epithelium (36, 37) . This transcription factor is central to cholesterol and glucose/energy metabolism as it controls hepatic expression of CYP7A1, CYP8B1, glucose-6-phosphatase, and phosphoenolpyruvate carboxykinase that play central roles in bile acid biosynthesis and hepatic gluconeogenesis (38, 39) . The morphogenetic parameters controlled by HNF4A in hepatocytes are essential for normal liver architecture, including the organization of the sinusoidal endothelium (37) .
Besides downregulation of multiple gene families, analysis of gene expression profile in livers from brain-dead subjects revealed several hepatic transcripts that were, conversely, elevated. Certain of these transcripts: ORM1, LBP, and SERPINA3, belong to the acute phase response reactants, and their induction indicates activation of systemic host responses (40 -42) . An interesting observation was the marked upregulation of the S100A8 gene. S100 proteins are involved in regulation of cell cycle progression and differentiation. These proteins belong to the recently recognized damageassociated molecular pattern molecules (DAMPs) (43) that are released upon tissue damage or injury, and are produced by phagocytes within inflamed tissues. They interact with molecules on target cells, mainly endothelium and immune cells, and induce recruitment of leukocytes at sites of inflammation (44) . Circulating S100 has been proposed as an outcome predictor for severe head injury victims and a marker for early diagnosis of brain death (45) . Our observation that livers from brain dead organ donors expressed very high levels of S100 (13-fold over control liver) indicates yet another source of this inflammatory protein during brain death.
The marked upregulation of CCL2 (monocyte chemoattractant protein-1) in livers from brain-dead subjects can contribute to tissue injury. This cytokine has chemotactic activity for mononuclear cells and has been implicated in the pathogenesis of acute rejection after liver transplantation (46) . Indeed, local synthesis of chemokines has major effects in recruitment and activation of leukocytes and consequent liver damage.
Livers of brain-dead subjects had enhanced transcription of mitochondrial respiratory chain components (cytochrome C oxidase subunits, NDUFA4), linked to oxidative metabolism and energy demand (47, 48) . Induction of these enzymes likely represents a compensatory mechanism to hypoxia-induced mitochondrial dysfunction. Cytochrome C oxidase, the terminal enzyme in the mitochondrial respiratory chain, catalyzes the reduction of molecular oxygen by reduced cytochrome C. It protects cells from insults and improves survival during sepsis (47) . NDUFA4 is an endogenous antioxidant that protects intracellular membranes from lipid peroxidation induced in aerobic metabolism (48) . In addition, there was marked upregulation of GPX2, an antioxidant enzyme belonging to the family of selenium-dependent glutathione peroxidases that reduces fatty acid hydroperoxides and prevents oxidative damage to the cell membrane (49) .
Finally, donor livers showed a massive induction (Ͼ35 fold) of CHI3L1. Upregulation of this molecule has been found in autoimmune hepatitis (50) and its increase during brain dead is consistent with liver inflammation.
Although the traditional focus in inflammation and immunity research has been upon events and mediators in the periphery, it is clear that the brain has the capacity to reduce or augment the inflammatory process. The existence of central anti-inflammatory influences on peripheral inflammation induced by peptides such as ␣-melanocyte stimulating hormone (51, 52) or thyrotropin releasing hormone (53) , and through cholinergic pathways (21, 54) is well documented. Conversely, inflammatory cytokines injected centrally enhance peripheral edema (55) and induce increases in neutrophils and acute phase proteins (56) . Central interleukin 1 reduces peripheral lymphocyte responses (57) . Certain neuropeptides can likewise enhance peripheral inflammation: for instance, central injection of corticotropin releasing factor (CRF) worsens experimental liver injury in rats (58) .
These observations have particular relevance when considering that cytokines and neuropeptides are altered within the CNS during brain injury. Indeed, both TBI and SAH are marked by enhanced cytokine production within the brain (59, 60) . Protective factors such as ␣-melanocyte stimulating hormone can be conversely reduced (61) . A recent research based on the cDNA microarray technique reported marked changes in gene expression profile in the rat cerebral cortex after traumatic injury (62) . Prominent gene changes included proinflammatory and proapoptotic molecules, heat shock proteins, neuropeptides, and glutamate receptor subunits (62) . Alterations in gene expression within the brain can help understanding of the changes observed in peripheral organs during brain death. Indeed, enhanced cytokine release within the brain during the phase of brain injury could account for altered gene expression in peripheral organs. Indeed, although trauma or infection during the phase that precedes death can contribute to organ deterioration, certain changes appear to be linked to brain death per se. This idea is supported by observations in controlled animal studies in which there were prominent changes in lung, kidney, and liver (2, 5, 15) even in the absence of the complications seen in clinical organ donors. A preclinical study accurately documented the distinct contribution of brain death and vascular instability on kidney dysfunction (6). Brain death was associated with inflammatory response in kidneys. When hemodynamic instability in the brain-dead donor was not corrected, kidney dysfunction was greater and the inflammatory reaction faster and more profound (6) .
In agreement with results of neuroimmunomodulation experiments, we found repression of two lymphocyte products, the late-onset chemokine CCL5 (RANTES) and the homeostatic chemokine CCL21 (63) in livers from brain-dead subjects. This observation suggests reduced activation of infiltrating lymphocytes and is consistent with experiments in rats in which interleukin 1 (IL-1) infused into the brain reduced peripheral lymphocyte responses (57): NK activity, response to phytohemagglutinin stimulation, and interleukin 2 production, were inhibited by central IL-1 through sympathetic efferent pathways from brain to the spleen.
In conclusion, the present research found several alterations in expression profile of livers from brain-dead organ donors. Downregulation of pathways of paramount importance for liver physiology likely impairs the capacity of the organ to accomplish its main functions in control of metabolism, morphogenesis, blood coagulation, and complement cascade. Of interest, the concomitant upregulation of acute phase and inflammatory response genes suggests that the alteration in the transcriptional profile of donor livers is not the consequence of death-associated organ failure but it rather stems from active changes in regulatory mechanisms.
